Metabolomic Discoveries

What Metabolomic Discoveries does

Metabolomic Discoveries is a privately held German analytical services company founded in 2009 and headquartered in Potsdam. It provides mass-spectrometry-based metabolite profiling, metabolite fingerprinting, stable isotope labelling, and biomarker discovery services to clients across industrial biotechnology, agriculture, food & ingredients, beverages, cosmetics, pharma/healthcare, and bioprocess. The company's core technical platform supports three profiling modes (polar metabolites, lipids, aroma compounds) across more than five sample classes ranging from microbes to body fluids, positioning it as a one-stop metabolomics service provider rather than a single-asset vendor.

The business model is B2B professional services: projects are initiated through direct inquiry (website contact forms and email), scoped consultatively, and delivered as defined analytical outputs (biomarkers, profiles, reports) under quote-based pricing. The primary stated customer segment is pharma and healthcare biomarker discovery, with the remaining six verticals treated as secondary use cases. Distribution is direct-to-client only, with no resellers or marketplace channels; marketing relies on the company website, LinkedIn, email newsletter, and industry events such as Analytica. There are no named customer logos, no disclosed leadership team, no partnerships, and no M&A activity in the source data.

Commercially, the company shows a single disclosed funding event of $800,000 dated 2010-09-28 and 11-50 employees, indicating a small, long-running, self-funded service business. In 2025 it expanded its aroma profiling offering for food and beverage clients and participated at the Analytica trade show. No AI/ML capabilities, patents, certifications, or regulatory milestones are disclosed in the input material.

Name

Metabolomic Discoveries

Legal name

Metabolomic Discoveries

Website

https://metabolomicdiscoveries.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Metabolomic Discoveries is a Potsdam-based analytical services company using mass spectrometry to deliver metabolite profiling, fingerprinting, and biomarker discovery to pharma, food, beverage, cosmetics, agriculture, and bioprocess clients.

Ownership category

akta.pro rank

Product category

Analytical Metabolomics Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Metabolomics & Lipidomics Services (HLAGANAG)

akta.pro secondary industries

Proteomics & Mass Spectrometry Services (HLAGANAB), Bioanalytical & Biomarker Assays (Preclinical) (HLAGAFAK)

Keywords

• Metabolite profiling services
• Biomarker discovery
• Mass spectrometry analysis
• Metabolomics services
• Metabolite fingerprinting

Headquarters

HQ city

Potsdam

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Analytical Services: B2B analytical service contracts for metabolite profiling, fingerprinting, and biomarker discovery. Clients engage for specific studies with defined deliverables (biomarkers, profiles, reports). Revenue generated through project-based service fees.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Metabolomic Discoveries is a B2B analytical service and research company that provides mass-spectrometry-based metabolite profiling and fingerprinting for industry and research clients. The company turns raw spectra into validated biomarkers across three profiling modes (polar metabolites, lipids, aroma compounds) applied to diverse sample classes ranging from microbes to body fluids.

Product overview

Metabolomic Discoveries offers a unified analytical service platform centered on mass-spectrometry-based metabolite profiling and fingerprinting. The company provides six core service modules: Comprehensive Metabolite Profiling (broad untargeted coverage), Targeted Metabolite Profiling (quantitative focus), Metabolite Fingerprinting (rapid sample comparison), Stable Isotope Labelling (metabolic flux tracing), Biomarker Discovery (statistical validation), and Consulting & Study Design. These services operate across three profiling modes—polar metabolites, lipids, and aroma compounds—and apply to diverse sample classes from microbes to body fluids. The platform is designed to serve multiple industries including industrial biotechnology, agriculture, food & beverage, cosmetics, and pharmaceuticals.

Differentiator

Problem solved

Functional benefit

Products and services

• Comprehensive Metabolite Profiling Broad, untargeted analytical service covering polar metabolites, lipids and aroma compounds in a single study, providing comprehensive metabolite identification and quantification for industry and research clients.
• Targeted Metabolite Profiling Quantitative analytical service focusing on the polar, lipid or aroma compounds that matter most to a client's specific research question.
• Metabolite Fingerprinting Rapid, holistic comparison of samples to flag differences before committing to deeper analysis, enabling quick sample classification.
• Stable Isotope Labelling Analytical service that traces metabolic flux and pathway activity with isotope-resolved measurement for understanding metabolic processes.
• Biomarker Discovery Statistical workflows that turn metabolite profiles into validated, decision-ready biomarkers for industry and research applications.
• Consulting & Study Design Expert guidance to help clients frame the right experiment before sample analysis, optimizing experimental design for meaningful metabolomics results.

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves3 records

Expansion highlights3 records

Broad incumbents

• Sciex: Sciex is a major mass spectrometry instrument and software provider whose technology underpins many metabolomics workflows; comparable as an incumbent that competes with and enables CROs in the metabolomics space.
• Waters Corporation: Waters is a leading mass spectrometry and chromatography vendor with deep penetration into metabolomics laboratories; comparable as an instrument incumbent whose platforms shape the competitive landscape for metabolomics services.
• Eurofins Scientific: Eurofins is a large global testing services group with metabolomics, food, cosmetics, and pharma testing capabilities; overlaps with Metabolomic Discoveries' food, beverage, cosmetics, and pharma testing applications under a much broader portfolio.
• Thermo Fisher Scientific: Thermo Fisher is a major instrument and CRO player in mass spectrometry, including metabolomics services through its Analytical Services and PPD CRO business; competes broadly with niche metabolomics services for both pharma biomarker work and industrial quality applications.

Regional players

• Metabolomics Australia: Metabolomics Australia is a national service node offering mass-spec-based metabolomics for academic and industrial clients; comparable core technology and workflow, though primarily serving the Australian market.
• MS-Omics: MS-Omics is a Danish metabolomics service provider using LC-MS for both untargeted and targeted metabolite profiling across food, pharma, and biotech clients; highly comparable service menu and customer base, with European regional overlap.

Direct peers

• Metabolon: Metabolon is the largest global metabolomics services CRO, offering untargeted and targeted metabolite profiling plus biomarker discovery for pharma, consumer products, and academic clients; directly comparable to Metabolomic Discoveries on core technology (mass spec), service menu, and target customers.
• Biocrates Life Sciences: Biocrates provides standardized targeted metabolomics kits and services, including lipid mediators and bile acids, for pharma and academic research; closely comparable as a metabolomics specialist selling quantitative mass-spec-based profiling and biomarker workflows.
• Human Metabolome Technologies (HMT): HMT offers capillary electrophoresis and LC-MS based metabolomics services, including biomarker discovery from body fluids, mirroring Metabolomic Discoveries' pharma and clinical metabolomics focus and consulting-led service model.

Emerging players

• Creative Proteomics: Creative Proteomics provides metabolomics and proteomics services using LC-MS and GC-MS, with overlapping offerings in untargeted profiling and biomarker discovery; comparable as a smaller, mass-spec-driven multi-omics service provider.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/mdiscoveries
• Facebookfacebook.com/marleen.vanbalkom
• LinkedInlinkedin.com/company/metabolomic-discoveries

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metabolomic Discoveries